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Abstract 
Background: Effector binding is important for transcription factors, affecting both the pattern and function of tran‑
scriptional regulation to alter cell phenotype. Our previous work suggested that the affinity of the global transcription 
factor catabolite repressor/activator (Cra) for its effector fructose‑1,6‑bisphosphate (FBP) may contribute to succinate 
biosynthesis. To support this hypothesis, single‑point and three‑point mutations were proposed through the semi‑
rational design of Cra to improve its affinity for FBP.
Results: For the first time, a positive correlation between succinate production and the affinity of Cra for FBP was 
revealed in Escherichia coli. Using the best‑fit regression function, a cubic equation was used to examine and describe 
the relationship between succinate production and the affinity of Cra for FBP, demonstrating a significant positive 
correlation between the two factors (coefficient of determination R2 = 0.894, P = 0.000 < 0.01). The optimal mutant 
strain was Tang1683, which provided the lowest mutation energy of −4.78 kcal/mol and the highest succinate 
concentration of 92.7 g/L, which was 34% higher than that obtained using an empty vector control. The parameters 
for the interaction between Cra and DNA showed that Cra bound to the promoter regions of pck and aceB to activate 
the corresponding genes. Normally, Cra‑regulated operons under positive control are deactivated in the presence of 
FBP. Therefore, theoretically, the enhanced affinity of Cra for FBP will inhibit the activation of pck and aceB. However, 
the activation of genes involved in CO2 fixation and the glyoxylate pathway was further improved by the Cra mutant, 
ultimately contributing to succinate biosynthesis.
Conclusions: Enhanced binding of Cra to FBP or active site mutations may eliminate the repressive effect caused by 
FBP, thus leading to increased activation of genes associated with succinate biosynthesis in the Cra mutant. This work 
demonstrates an important transcriptional regulation strategy in the metabolic engineering of succinate production 
and provides useful information for better understanding of the regulatory mechanisms of transcription factors.
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Background
Escherichia coli has been widely engineered for succi-
nate production with high titers through the inactivation 
or overexpression of key genes associated with succi-
nate biosynthesis [1–3]. However, due to the complexity 
of the metabolic network, occasionally the desired cell 
phenotype may not be obtained through gene manipu-
lation. Global regulation has attracted increasing atten-
tion because of its effective regulation of the expression 
of multiple pathway-related genes [4] and required cell 
phenotypes [5]. Furthermore, transcriptional engineer-
ing approaches have been regarded as important [6, 7]. 
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In prokaryotes, gene expression is controlled by tran-
scription factors (TFs) via their binding to specific DNA 
sequences [8]. TFs are important components of gene 
regulatory networks and respond to changes in the cel-
lular environment by altering the expression of relevant 
genes [9]. Catabolic repressor/activator (Cra), also known 
as FruR, is a global TF [10, 11]. It is a dual regulator that 
controls the expression of a large number of metabolic 
genes that encode enzymes associated with the gluconeo-
genic pathway [12], the Krebs cycle and glyoxylate shunt 
[13], the Entner Doudoroff pathway [14], and the glyco-
lytic pathway [15, 16].
As a member of the GalR-LacI family, Cra comprises 
two functional domains: the N-terminal DNA-binding 
domain and the C-terminal regulatory domain [17, 18]. 
The regulatory domain affects the regulatory function of 
Cra by altering the affinity of its DNA-binding domains 
for DNA upon effector binding [19]. In many TFs, effector 
binding has major consequences on the protein structure 
and function [20–22]. The effects of Cra on transcription 
via binding to the promoter regions of its target genes 
can be counteracted by its effectors, including fructose-
1-phosphate (F1P) and fructose-1,6-bisphosphate (FBP) 
[15, 19]. In our previous work, a Cra mutant strain 
with 22.8% higher succinate production was obtained 
through random mutation and screening. Correspond-
ingly, a higher Cra-FBP affinity (Kd = 130 ± 37 nM) was 
obtained, while the Kd value of wild-type Cra with FBP 
was 1400 ± 150 nM. It suggested that the enhanced bind-
ing affinity of the Cra mutant for FBP may contribute to 
succinate biosynthesis [23]. However, research on how 
changes in effector binding affinity modulate DNA-bind-
ing and, therefore, the cell phenotype, is limited.
To further clarify the mechanism of Cra in transcrip-
tional regulation through effector binding and to support 
the hypothesis on the relationship between succinate 
production and the affinity of Cra for FBP, a strategy to 
achieve high binding affinity based on a semi-rational 
design was developed. A best-fit approach was then 
used to select regression models to best describe the 
relationship between succinate production and binding 
affinity. Finally, the regulatory effects of the optimal Cra 
mutants on genes associated with succinate biosynthe-
sis and properties of the effector-Cra-DNA complexes 
were investigated. This work provides useful information 
regarding the transcriptional regulation of target product 
biosynthesis and represents a powerful approach for the 
production of other industrially important chemicals.
Methods
Strains, plasmids, and chemicals
All strains and plasmids used in this study are listed in 
Additional file 1. Primers are summarized in Additional 
file 2. During strain construction, the strains were cul-
tured aerobically at 37  °C in Luria broth (5  g/L yeast 
extract, 10 g/L tryptone, and 10 g/L NaCl). The E. coli 
strain DH5α was used for plasmid construction. E. 
coli BL21 cells were used for the expression and puri-
fication of Cra. E. coli AFP111 was kindly provided by 
Dr. David P. Clark at Southern Illinois University [24]. 
The plasmids pTrc99A and pET28a were used as foun-
dation plasmids to prepare constructs and for overex-
pression. rTaq DNA polymerase and primeSTAR HS 
DNA polymerase were purchased from Takara (Takara, 
Dalian, China). Restriction enzymes and T4 DNA ligase 
were obtained from New England Biolabs (Ipswich, 
USA), while the Cycle-Pure Kit, the Gel Extraction Kit, 
the Bacteria RNA Kit, and the Plasmids Mini Kit were 
obtained from Omega (Omega Bio-Tek, Doraville, 
USA).
Protein structure validation and active site prediction
Crystal structures were downloaded from the RSCB Pro-
tein Data Bank (PDB) database under the following PDB 
ID: 2IKS (effector-free Cra from E. coli). The molecular 
models of FBP were prepared and energy-minimized 
in the Avogadro 1.0.2 package. Individual chains of Cra 
structures were aligned to chain A of the 2IKS structure 
using Discovery Studio (DS) 4.0.
Energy minimization of the Cra protein structure was 
performed by applying the “prepare protein” protocol of 
DS. Binding active sites were predicted using the “define 
and edit binding site” protocol of DS.
Molecular docking calculations
The general docking protocol was performed as previ-
ously described [25]. Possible binding models between 
Cra and FBP were examined using the CDOCKER pro-
tocol of DS 4.0. The algorithm employs CHARMm force 
fields. A site sphere radius of 10 Å was set to assign the 
binding pocket.
Computer‑assisted virtual mutation
Computer-assisted virtual mutation was used to select 
mutations to improve the binding affinity of Cra for FBP. 
The amino acid residues at the active site were replaced 
with 17 common amino acids using the calculate muta-
tion energy/stability module of DS 4.0. Mutation energy 
was the only standard used to evaluate the effect of the 
mutations on protein stability. The optimal mutants 
with the lower mutation energy, representing the higher 
binding affinity, were selected. The mutation energy 
was calculated as the sum of van der Waals, electro-
static, non-polar, and entropy terms. The single-point 
and three-point mutations were generated using overlap 
extension PCR.
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Anaerobic bottles culture
The pre-culture and fermentation medium consisted 
of the following components (g/L): glucose 40, yeast 
extract 10, tryptone 20, K2HPO4·3H2O 0.9, KH2PO4 1.14, 
CaCl2· 3H2O 0.25, (NH4)2SO4 3.0, MgSO4·7H2O 0.5, and 
VB1 1  mg. For the first preculture, fresh colonies were 
picked from LB agar plates supplemented with ampicillin 
(100 mg/L), chloramphenicol (34 mg/L), and kanamycin 
(34  mg/L). Medium (50  mL) was prepared in a 250-mL 
flask, and a colony from a plate culture was inoculated 
and then incubated for 10 h at 37 °C on a rotary shaker at 
180 rpm. For the second pre-culture, 50 mL of medium 
was prepared in a 250-mL rotary shaker, inoculated with 
200  μL of the first pre-culture broth and incubated for 
10 h at 37 °C on a rotary shaker at 180 rpm. For fermen-
tation, 5% (v/v) of the second pre-culture was inoculated 
into anaerobic bottles containing 50  mL fermentation 
medium. After aerobic growth at 37  °C and shaking at 
180 rpm for 4 h, 40 g/L MgCO3 was added, and a small 
amount of CO2 was vented. Cells were then transferred 
to anaerobic conditions by rubber plug. Samples were 
obtained after 96 h, and three replicates were performed 
in parallel.
Fed‑batch culture
Details of the preculture medium and preculture condi-
tions have been previously described [26]. Dual-phase 
fed-batch fermentation was conducted with 5 L of initial 
fermentation medium in a 7.5-L BioFlo 115 fermenter 
(New Brunswick Scientific, USA). A 5% (v  v−1) inocu-
lums from the second preculture was used. During aer-
obic fermentation, the initial sugar concentration was 
35  g/L. The dissolved oxygen (DO, approximately 40%) 
was controlled by adjusting the agitation speed and aera-
tion rate. When the residual sugar concentration was 
less than 1 g/L, the aerobically grown cells were directly 
transferred to anaerobic conditions, and the glucose 
concentration was adjusted to 40  g/L by supplying glu-
cose as an 800 g/L solution. A rotation speed of 400 rpm 
and 0.1 vvm of external CO2 gas were used. The pH was 
maintained at 7.0 using 20 g/L MgCO3 and 5 M NaOH. 
In the subsequent fermentation process, when the resid-
ual sugar concentration fell to less than 10  g/L, glucose 
was added to achieve 40  g/L. Cell mass and measure-
ments of the residual sugar and succinate concentrations 
were determined as previously reported [26].
Six cultures were carried out simultaneously in stirred-
tank bioreactors containing different engineered strains 
under identical experimental conditions; this method 
ensured that accurate head-to-head comparisons could 
be made. The results presented here were reproducible in 
another experiment (data not shown).
RT‑qPCR
E. coli AFP111 cells transformed with plasmids were col-
lected at 10 h (the onset of anaerobic culture) during the 
dual-phase fed-batch fermentation, and total RNA was 
extracted using a Bacterial RNA Kit (Omega Bio-Tek, 
Doraville, USA). Total RNA fragments were reverse-tran-
scribed into cDNA using the PrimeScript™ RT Reagent 
Kit (Takara, Dalian, China). And 16S rRNA was used as 
the endogenous control. All cDNA samples were diluted 
to a final concentration of 10 ng/µL. A two-step RT-PCR 
kit with SYBR Green was used with a thermal cycler (iCy-
cler, Bio-Rad, USA) for RT-qPCR. Primers were used at 
final concentrations of 0.2 µM, and 10 ng of cDNA was 
used as a template in each 20 µL reaction. The threshold 
cycles for each sample were calculated based on fluores-
cence data using proprietary software (Bio-Rad, USA).
Enzyme activity
To measure enzyme activity, cells were harvested at the 
onset of anaerobic culture (10  h) (i.e., at the end of the 
aerobic phase) during fermentation via centrifugation 
(12,000×g at 4  °C). Cells were resuspended in 50  mM 
potassium phosphate buffer (pH 7.4) and disrupted on ice 
for 15 min (with a working period of 3 s and a 5-s inter-
val constituting each cycle) at a power output of 200 W 
using an ultrasonic disruptor (J92-II, Xinzhi, Ningbo, 
China). Unbroken cells were removed by centrifugation 
at 10,000×g for 20 min, and the supernatant was further 
centrifuged at 10,000×g for 10 min. The resulting super-
natant was used in the enzyme activity assays. Enzyme 
activities were measured using a spectrophotometer 
(UV-1100, MAPADA, Shanghai, China).
All protocols used for the enzyme activity assays have 
been described in previous studies and were optimized 
for the conditions and media used in this study. Phosphof-
ructokinase (PFK) [27], phosphoenolpyruvate carboxylase 
(PPC) [28], phosphoenolpyruvate carboxykinase (PCK) 
[28], malate dehydrogenase (MDH) [29], fumarase (FUM) 
[30], fumarate reductase (FRD) [28], malate synthetase 
(MS) [31], isocitrate lyase (ICL) [28], citrate synthetase 
(CS) [32], and isocitrate dehydrogenase (ICD) [33] were 
measured. The wavelength used to determine NAD+, 
NADH, NADP+, and NADPH were 340 nm, respectively. 
Fumarate and malate formation were recorded at 240 
and 578 nm, respectively. One unit (U) of enzyme activ-
ity represents the amount of enzyme required to catalyze 
the conversion of 1 µmol of substrate per min into specific 
products. The total protein concentration in the crude 
cell extracts was measured using a BCA Protein Assay 
Kit (Beyotime, China). Enzyme assays were performed in 
triplicate, and if the discrepancy between the results was 
greater than 10%, another pair of assays was performed.
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Cloning, expression, and protein purification
The DNA sequence encoding the Cra protein was ampli-
fied from E. coli AFP111 using the primers Cra-SacI-
F and Cra-His-HindIII-R. To aid in the purification of 
Cra, a His-tag-encoding fragment was included in the 
construct. The resulting PCR product was digested 
with SacI/HindIII and cloned into the expression vec-
tor pET28a. The resulting plasmid (pET-cra) was trans-
formed into E. coli BL21 cells. For the expression of the 
His6-tagged protein, the transformed strain was grown in 
LB medium at 37 °C to an OD600 = 1.0. Gene overexpres-
sion was induced by the addition of 1 µM isopropyl-β-D-
thiogalactopyranoside (IPTG) (Biosharp, Seoul, Korea). 
Cells were cultured overnight.
The cells were then centrifuged at 4600×g for 15 min, 
and the pellets resuspended in phosphate-buffered saline 
(PBS) (pH 7.4), after which time the cells were disrupted 
on ice using an ultrasonic disruptor (J92-II, Xinzhi, 
Ningbo, China). Unbroken cells were removed by centrif-
ugation at 10,000×g for 30 min. Finally, the proteins were 
resuspended in 100  mM Tris buffer (pH 6.8) (ANGUS, 
USA) containing 10% β-mercaptoethanol (AMRESCO, 
USA), and the suspension was stored at −80 °C. For puri-
fication, the native His6-Cra protein was isolated from 
the cell lysate supernatant using Ni metal affinity resin 
(Clontech, USA) according to the manufacturer’s instruc-
tions. The purified protein was stored in elution buffer at 
4 °C until use, as indicated in each case.
Non‑radioactive electrophoretic mobility shift assay 
(EMSA)
EMSA was performed as previously described [34]. The 
18-bp DNA fragment used for EMSA was prepared by 
heating a 50  nM mixture of complementary oligonu-
cleotides containing the presumed Cra binding site of 
the pck and aceB promoter regions in 1 mL TE buffer at 
95 °C for 10 min. The annealed product was maintained 
on ice until use. Cra was incubated with the DNA frag-
ment in the presence of 1 mM FBP (Sigma-Aldrich, 98% 
purity). Reaction mixtures were incubated for 15  min 
at 30  °C and electrophoresed on a non-denaturing 10% 
(w/v) polyacrylamide gel. The gels were stained with eth-
idium bromide and visualized using a gel imaging system 
(Tanon-1600, China).
Isothermal titration microcalorimetry (ITC)
ITC experiments were performed using a TAM III 
instrument (Q Series Thermal Analysis) at 25 °C. Cra was 
thoroughly desalted using PD-10 desalting columns (GE, 
USA). The protein concentration of the desalted solution 
was determined using a BCA protein assay kit. Each ITC 
titration involved 10 μL injections of 50 mM FBP into a 
15 μM protein solution that was placed into the 1.4-mL 
chamber of the apparatus. ΔH (reaction enthalpy), KA 
(binding constant), and n (reaction stoichiometry) were 
determined based on the fitted curves. The changes in 
free energy (ΔG) and entropy (ΔS) were calculated using 
the following equation: ΔG  =  −RTlnKA  =  ΔH  −  TΔS, 
where R is the universal molar gas constant and T is the 
absolute temperature.
Statistical analyses
The data were analyzed using IBM SPSS 19 (SPSS Inc., 
Chicago, IL). P values less than 0.05 were considered 
significant.
Results and discussion
Docking of Cra and FBP to identify the active sites 
for improved affinity
To determine whether the enhanced binding affinity of 
each Cra mutant for its effector promotes succinate bio-
synthesis, a semi-rational strategy based on computer-
assisted virtual saturation mutagenesis was devised to 
enhance the affinity of Cra for FBP. Due to the lack of com-
plete crystal structure information on Cra, the structure 
of the regulatory domain (PDB ID: 2IKS) was utilized to 
model the effector-binding pocket by computational dock-
ing algorithms. The docked position was compared to the 
crystal structure of the regulatory domain by calculating 
root mean square deviation (RMSD) values. As shown 
in Fig. 1, 4 amino acids that directly interacted with FBP 
(Asp148, Arg149, Arg197, and Arg323) and 16 amino acids 
that indirectly interacted with FBP (Asn73, Ser75, Tyr76, 
Asp101, Leu191, Val193, Tyr220, Thr245, Ser246, Phe247, 
Ala248, Phe273, Gly274, Asp275, Gln291, and Lys322) 
were identified. These amino acids may play a significant 
role in the affinity of Cra for FBP. Thus, these 20 amino 
acids were selected as possible sites for mutagenesis.
Correlations between succinate production and the affinity 
of Cra for FBP
Computer-assisted virtual saturation mutagenesis was 
carried out on this group of mutants to determine the 
optimal single-point mutants using the mutation energy 
as the unique standard to evaluate mutant stability and 
affinity. A negative mutation energy indicated that the 
mutation would enhance the interaction between Cra 
and FBP. Based on the assumption that the lower muta-
tion energy represents the more stable protein struc-
ture and higher binding affinity, 37 single-point mutant 
strains were selected from more than 300 virtual mutant 
strains (Table 1), including 29 mutant strains (Tang1646-
Tang1674) with lower mutation energy. To more accu-
rately fit the relationship between affinity and succinate 
production, 8 mutation strains (Tang1675-Tang1682) 
with higher mutation energy were also selected.
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The effects of single-point Cra mutations on succinate 
production are shown in Table  1. To describe the rela-
tionship between succinate production and the affin-
ity of Cra for FBP, a best-fit approach was used to select 
regression models—considering linear, logarithmic, 
quadratic, cubic, power, and exponential methods. The 
cubic regression model was chosen as the best model to 
determine the correlation between the binding affinity 
and succinate production. As shown in Fig. 2 and Addi-
tional file 3, within the mutation energy range examined, 
succinate production increased with increasing muta-
tion energy (coefficient of determination R2  =  0.894, 
P =  0.000  <  0.01). These results suggested a significant 
positive correlation between the two variables within a 
certain range.
Because the increased binding affinity caused by sin-
gle-point mutation was limited, three-point mutations 
were designed using the Calculate Mutation Energy/
Stability module of DS 4.0 to provide increased affinity 
beyond what could be obtained by incorporating a single 
mutation. Based on the above results, all 37 single-point 
mutation sites were combined to form three-point muta-
tions. The optimal three-point mutants were selected, 
in which mutation energy were lower than the low-
est energy in single-point mutation. Finally, 17 optimal 
three-point mutant strains were generated (Table 2). Due 
to the extension of the affinity range, a fitting analysis 
of mutation energy data and succinate production was 
conducted using the cubic regression model. As shown 
in Fig. 3a, a high correlation between the mutation ener-
gies of the three-point mutants and succinate production 
was revealed (coefficient of determination R2  =  0.840, 
P  =  0.000  <  0.01), proving that the affinity of the Cra 
mutant closely reflects the level of succinate produc-
tion. Thus, succinate production improves with increased 
binding affinity.
Figure  3b shows the succinate production of the 17 
three-point mutant strains in a 7.5-L bioreactor. Time 
profiles of the fed-batch culture are summarized in Addi-
tional file 4. Increased succinate production was obtained 
with Tang1683 (Asp101Arg/Asp148Arg/Gly274Arg), 
Tang1684 (Asp148Arg/AlaA248Phe/Gly274Arg), and 
Tang 1688 (Asn73Tyr/Asp148Arg/Gly274Arg). The lev-
els were 34, 30, and 28% higher, respectively, than that 
obtained with empty vector control Tang1509. These 3 
optimal mutant strains were selected for further analysis.
Structural basis for the improved affinity
To investigate the mechanism responsible for the 
improved affinity, the structures of the wild-type Cra 
and the optimal three-point mutants were compared. As 
shown in Fig. 4a, three hydrogen bonds and five electro-
static interactions were observed in the wild-type Cra 
model. The Cra mutations in Tang1683 resulted in four 
Fig. 1 Crystal structure of Cra (PDB: 2IKS) and the docked model of Cra with FBP
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additional hydrogen bonds involving amino acids Asp101 
and Arg197 and two additional electrostatic interactions 
(Fig. 4b). The Cra mutations in Tang1684 resulted in seven 
additional hydrogen bonds, while two additional hydrogen 
bonds and four additional electrostatic interactions were 
observed in the Cra mutant Tang1688 (Fig.  4c, d). The 
additional interaction forces may have led to closer bind-
ing between Cra and FBP. The energy changes in the Cra-
FBP binding complexes were 4.78, 4.29, and 3.89 kJ/mol in 
Tang1683, Tang1684, and Tang1688, respectively (Table 2).
To determine whether the affinities of the Cra mutants 
for FBP were enhanced, the interaction parameters of 
the Cra protein with FBP were examined by ITC. As 
shown in Fig.  5a, the binding of wild-type Cra to FBP 
was an exothermic process (ΔH = −27.4 ± 1.3 MJ/mol, 
ΔS  =  −54.8  ±  0.8  kJ/mol, ΔG  =  −16.8  ±  1.4  kJ/mol). 
Subsequent calculations allowed us to determine a Cra-
FBP dissociation constant (Kd) of 1360 ± 6.2 nM, reflect-
ing an interaction between FBP and wild-type Cra. The 
results shown in Fig.  5b indicate that the binding of 
Table 1 The characteristic of single-point mutations, mutation energy, and succinate production
Strain Residue Mutated to Mutation energy (kcal/mol) Effect Succinate production (g/L)
Tang1646 Asp148 Arg −3.15 Stabilizing 33.8
Tang1647 Gly274 Arg −3.04 Stabilizing 33.2
Tang1648 Asp101 Arg −2.84 Stabilizing 36.7
Tang1649 Ser75 Lys −2.60 Stabilizing 35.0
Tang1650 Tyr220 Lys −2.40 Stabilizing 32.7
Tang1651 Asp148 Lys −2.34 Stabilizing 34.8
Tang1652 Leu191 Lys −2.04 Stabilizing 34.2
Tang1653 Asn73 Tyr −1.92 Stabilizing 32.2
Tang1654 Ser246 Lys −1.90 Stabilizing 32.1
Tang1655 Phe273 Lys −1.58 Stabilizing 31.6
Tang1656 Tyr76 Arg −1.51 Stabilizing 31.6
Tang1657 Asp275 Glu −1.50 Stabilizing 32.5
Tang1658 Gln291 Arg −1.32 Stabilizing 32.2
Tang1659 Ala248 Lys −1.22 Stabilizing 33.9
Tang1660 Arg323 Lys −1.06 Stabilizing 31.7
Tang1661 Asn73 Arg −1.05 Stabilizing 32.6
Tang1662 Ser75 Arg −1.04 Stabilizing 31.3
Tang1663 Thr245 Ser −1.04 Stabilizing 30.6
Tang1664 Asp275 Gln −1.02 Stabilizing 30.5
Tang1665 Asn73 Phe −0.84 Stabilizing 31.8
Tang1666 Lys322 Asp −0.84 Stabilizing 32.7
Tang1667 Phe247 Pro −0.81 Stabilizing 32.4
Tang1668 Thr74 Lys −0.75 Stabilizing 32.0
Tang1669 Ala248 Phe −0.72 Stabilizing 30.5
Tang1670 Arg149 Lys −0.67 Stabilizing 31.4
Tang1671 Asp148 Glu −0.40 Destabilizing 33.1
Tang1672 Tyr220 Pro −0.22 Destabilizing 32.0
Tang1673 Tyr220 Leu −0.20 Destabilizing 29.0
Tang1674 Arg197 Lys −0.04 Destabilizing 30.4
Tang1675 Phe247 Glu 0.38 Destabilizing 31.3
Tang1676 Tyr76 Asp 0.95 Destabilizing 30.1
Tang1677 Phe247 Arg 1.08 Destabilizing 29.3
Tang1678 Ser75 Glu 1.65 Destabilizing 27.0
Tang1679 Arg149 Phe 1.65 Destabilizing 29.8
Tang1680 Arg149 His 2.24 Destabilizing 27.2
Tang1681 Gln291 Met 2.54 Destabilizing 25.7
Tang1682 Gln291 Trp 3.57 Destabilizing 24.3
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FBP to the Cra mutant (Tang1683) was enthalpy-driven 
(ΔH = −10.2 ±  0.7  MJ/mol) and produced a total free 
energy change (ΔG  =  −18.8  ±  1.2  kJ/mol). Favora-
ble (negative) enthalpy changes can be attributed to 
hydrogen bonding or a van der Waals force interaction 
between FBP and amino acids at the effector-binding 
site. Further calculations revealed a high protein-effector 
affinity (Kd = 154.2 ± 4.3 nM). The interaction results for 
the Tang1684 Cra mutant with FBP were similar to those 
of Tang1683 (Fig. 5c). The interaction was both enthalpy-
driven (ΔH = −21.0 ± 1.3 MJ/mol) and entropy-driven 
(ΔS = 54.7 ± 2.3 kJ/mol), producing a total free energy 
change (ΔG = −16.3 ± 0.7 kJ/mol). Moreover, the pro-
tein-effector affinity was high (Kd  =  728.3  ±  3.8  nM). 
The interaction results for the Tang1688 Cra mutant 
with FBP are shown in Fig.  5d. The interaction was 
enthalpy-driven (ΔH  =  −16.3  ±  0.8  MJ/mol), produc-
ing a total free energy change (ΔG  =  −23.4  ±  0.4  kJ/
mol). A high protein-effector affinity was also observed 
(Kd  =  809.1  ±  4.6  nM), indicating that the mutation 
enhanced the affinity of Cra for FBP and suggesting that 
the improved succinate production by the Cra mutant 
is likely associated with the improved affinity of Cra for 
FBP.
The expression levels of genes and activities of enzymes 
involved in succinate biosynthesis are affected by Cra 
mutations
To explore the effects of Cra mutations on succinate 
biosynthesis, first, the mRNA transcripts from 11 genes 
involved in succinate biosynthesis were analyzed using 
semi-quantitative RT-qPCR. The activities of 10 enzymes 
were then measured during the fermentation period. The 
11 genes, including pfkB (encoding phosphofructokinase, 
PFK), ppc (encoding phosphoenolpyruvate carboxylase, 
PPC), pck (encoding phosphoenolpyruvate carboxykin-
ase, PCK), mdh (encoding malate dehydrogenase, MDH), 
fumB (encoding fumarase, FRD), frdA (encoding fuma-
rate reductase, FUM), gltA (encoding citrate synthetase, 
CS), icd (encoding isocitrate dehydrogenase, ICDH), 
aceA (encoding isocitrate lyase, ICL), aceB (encoding 
malate synthetase, MS), and iclR (encoding IclR tran-
scriptional repressor), and 10 corresponding enzymes 
Fig. 2 Correlation between succinate production by single‑point 
mutant strains and the affinity of the Cra mutants for FBP
Table 2 The characteristic of three-point mutations, mutation energy, and succinate production
Strain Mutated to Mutation energy (kcal/mol) Succinate production (g/L)
Tang1683 Asp101Arg + Asp148Arg + Gly274Arg −4.78 92.7
Tang1684 Asp148Arg + Ala248Phe + Gly274Arg −4.29 90.0
Tang1685 Asp148Arg + Tyr220Lys + Gly274Arg −4.19 79.1
Tang1686 Asp101Arg + Asp148Arg + Ser246Lys −4.03 79.3
Tang1687 Asp148Arg + Gly274Arg + Asp275Gln −3.99 79.4
Tang1688 Asn73Tyr + Asp148Arg + Gly274Arg −3.89 88.3
Tang1689 Ser75Lys + Ala248Phe + Gly274Arg −3.75 77.5
Tang1690 Asp148Arg + Thr245Ser + Gly274Arg −3.68 78.9
Tang1691 Asp148Arg + Ser246Lys + Gly274Arg −3.63 73.7
Tang1692 Ser75Lys + Ser246Lys + Gly274Arg −3.45 75.0
Tang1693 Asp148Arg + Ser246Lys + Phe247Pro −3.36 73.5
Tang1694 Asp148Arg + Phe273Lys + Gly274Arg −3.36 73.6
Tang1695 Asp148Arg + Tyr220Lys + Ser246Lys −3.33 69.8
Tang1696 Asp148Arg + Phe247Pro + Gly274Arg −3.22 70.3
Tang1697 Asp148Arg + Ser246Lys + Ala248Phe −3.18 70.3
Tang1698 Ser75Lys + Phe273Lys + Gly274Arg −3.17 70.1
Tang1699 Ser75Lys + Gly274Arg + Asp275Gln −3.16 69.8
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Fig. 3 Correlation between succinate production by three‑point mutant strains and affinity of the Cra mutants for FBP (a). Succinate production by 
the wild‑type and three‑point mutants in a bioreactor (b)
Fig. 4 Predicted interaction between Cra and FBP in Tang1534 (a), Tang1683 (b), Tang1684 (c), and Tang1688 (d). Blue and green arrows indicate 
hydrogen bonds, and pink arrows indicate electrostatic interactions
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Fig. 5 ITC assays with Cra and FBP. For titration, Cra at the concentration of 15 mM was introduced into sample cells; the ligand concentration in 
buffer was 50 mM. The titration of FBP with Cra of Tang1534 (a), Tang1683 (b), Tang1684 (c), and Tang1688 (d)
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were selected based on their association with succinate 
biosynthesis.
As shown in Fig.  6a, RT-qPCR revealed that pck and 
aceB were significantly up-regulated in Tang1683, 
Tang1684, and Tang1688. Cra acts as an activator of 
genes involved in the glyoxylate shunt [13] and pck 
involved in phosphoenolpyruvate (PEP) carboxylation 
[16]. After mutating Cra, this activation was enhanced, 
confirming that the glyoxylate shunt and PEP carboxy-
lation are important pathways for succinate biosyn-
thesis [26, 35]. These obvious positive transcriptional 
influences may promote the biosynthesis of succinate. It 
should be noted that ppc was up-regulated in Tang1688 
and that aceA was down-regulated in Tang1683 and 
Tang1688, although previous studies have demon-
strated that Cra inhibits ppc and activates aceA [13, 36]. 
These results suggest that Cra mutations may partially 
change its regulatory mode and effects. Mutations in 
Asn73 and Asp101 were particularly important for the 
regulatory function of Cra. However, after mutation, 
the expression levels of 27 genes involved in the gly-
colytic pathway, the sugar phosphotransferase system, 
Fig. 6 Effect of Cra mutation on the relative expression levels of genes (a) and the activities of enzymes (b) involved in succinate biosynthesis. 
Central metabolism of E. coli. PFK phosphofructokinase, PPC phosphoenolpyruvate carboxylase, PCK phosphoenolpyruvate carboxykinase, MDH 
malate dehydrogenase, FUM fumarate, FRD fumarate reductase, CS citrate synthase, ICDH isocitrate dehydrogenase, ICL isocitrate lyase, MS malate 
synthetase. Experiments were conducted in triplicate, and the error bars represent the standard deviation
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and propionate catabolism, among other areas, which 
should be repressed by Cra, were still down-regulated 
(data not shown). The expression levels of genes involved 
in the reductive branch (mdh, fumB, and frdA) of the 
TCA cycle were partially up-regulated in Tang1683 and 
Tang1688. This result may be due to the interaction 
between Cra and other transcription factors, such as 
cyclic AMP receptor protein (CRP). In a previous report, 
Cra positively controlled the expression of the crp gene 
[37], while mdh and fumB were activated by CRP [38].
As shown in Fig.  6b, PFK activity was the highest in 
Tang1534. This result indicates that PFK is activated by 
Cra overexpression but not by its mutation. After mutat-
ing Cra, the activity of PPC decreased, while PCK activity 
significantly increased. The patterns of PCK activity were 
similar to those observed by expressing the correspond-
ing genes, suggesting that PCK is the main enzyme cata-
lyzing PEP carboxylation in the Cra mutants and that the 
obvious enhancement of gene expression and PCK activ-
ity may promote succinate biosynthesis. Active PEP car-
boxylation may increase the concentration of oxaloacetate 
(OAA), which could activate enzymes involved in the 
reductive TCA cycle as substrates. The activities of FUM, 
FRD, and CS were all improved after mutation. However, 
the activity of ICDH, which catalyzes the conversion of 
isocitrate to α-ketoglutarate, decreased after mutation, 
suggesting that the intermediate isocitrate is shunted by 
other branches such as the glyoxylate pathway. This infer-
ence was proven by the enhanced ICL activity. MS activ-
ity was the highest in the Cra mutant (Tang1684). The 
enhanced activities of enzymes in the glyoxylate pathway 
may thus promote succinate biosynthesis.
In summary, most genes and enzymes involved in PEP 
carboxylation, the glyoxylate pathway, and the reductive 
TCA cycle were activated due to the mutation of Cra 
either directly or indirectly, in particular pck and aceB. 
This activation may explain why succinate production 
was significantly improved after mutation. These pheno-
types are similar to those reported in other global regula-
tory reports [4]. When E. coli NZN111 cells were grown 
aerobically on acetate, succinic acid production was 
greatly improved without further genetic modifications. 
Additionally, the activities of ICL, MDH, and PCK were 
greatly enhanced, suggesting that global regulation could 
be an effective approach by which to enhance succinate 
production.
Enhanced DNA binding by Cra mutation
To verify that the activation of pck and aceB was directly 
caused by Cra mutation, a non-radioactive EMSA was 
conducted to demonstrate the binding of DNA to Cra. 
As shown in Fig. 7a, when Cra was present in the reac-
tion alone, increasing amounts of Cra enhanced binding. 
To more clearly describe the changes in binding, a gray-
scale analysis was performed (Fig.  7b). The band inten-
sity increased with increasing Cra concentrations, and 
the amount of free DNA decreased with decreasing Cra 
concentrations. Compared with wild-type Cra, the bind-
ing of the pck promoter sequence to the Cra mutants 
was enhanced. When Cra was present with FBP, there 
was no significant change in the interaction between 
wild-type Cra and pckp (Fig. 7c). The binding of pckp to 
the Cra mutants was further enhanced in the presence 
of FBP, particularly in Tang1683 (Fig.  7d). As shown in 
Fig. 7e, the binding of pckp (Tang 1534) to Cra with FBP 
was an endothermic process (ΔH  =  −27.4  ±  1.3  MJ/
mol, ΔS  =  −91.8  ±  1.4  kJ/mol, ΔG =  −16.8  ±  0.5  kJ/
mol). The Kd values of pckp binding to Cra in Tang1534, 
Tang1683, Tang1683, and Tang1688 were 1123.6 ±  4.2, 
90.9 ± 0.6, 133.3 ± 1.3, and 171.0 ± 1.6 nM, respectively, 
despite previous reports suggesting that Cra-regulated 
operons under positive control would be deactivated in 
the presence of FBP [15, 19]. Therefore, theoretically, the 
enhanced interaction between Cra and FBP would inhibit 
the activation of pck. However, after Cra mutation, the 
activation of genes involved in CO2 fixation was further 
improved with enhanced binding affinity (Fig.  6a). This 
result indicates that FBP is invalid and can be explained 
by two possibilities: first, when the affinity of Cra for FBP 
increased, the close interaction affected the regulatory 
function of FBP, thereby eliminating the inhibitory effect 
of FBP on Cra, and the elimination effect was enhanced 
with increased binding affinity; second, mutation of the 
active sites may have led to changes in the structure of 
the binding cavities, so that FBP could not perform its 
normal regulatory functions by binding to Cra. In this 
situation, when the binding affinity of the Cra mutants 
for FBP was enhanced, the positive effect of Cra on the 
expression of genes (such as pck) was further strength-
ened, ultimately contributing to succinate biosynthesis.
The binding of aceB promoter sequences to Cra was 
similar to that of pckp. This set of data clearly demon-
strates that compared to wild-type Cra, the binding 
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affinity of aceBp to the Cra mutants was enhanced in 
the presence of FBP (Fig.  8c, d). However, when FBP 
was absent, the enhanced interaction was accompa-
nied by the increased protein concentrations of the Cra 
mutants (Fig.  8a, b). The Kd values of aceBp binding to 
Cra with FBP in Tang1534, Tang1683, Tang1683, and 
Tang1688 were 1102.2  ±  4.7, 271.8  ±  1.3, 340.1  ±  1.8, 
and 410.0 ± 2.6 nM, respectively (Fig. 8e). The contacts 
between aceBp and Cra led to a lower affinity bind-
ing interaction than that between pckp and Cra. This 
weakened interaction was consistent with the decreased 
level of gene expression.
Conclusions
To support the hypothesis regarding the relationship 
between succinate biosynthesis and the binding affin-
ity of Cra for FBP, several saturation mutations aimed 
at improving binding affinity were generated through 
the semi-rational design of the Cra protein. As the most 
appropriate model, cubic regression was used to describe 
Fig. 7 The combination of Cra and pckp by EMSA and ITC experiments. EMSA experiment with increasing concentrations of pure Cra protein. Molar 
ratios of pckp:Cra were 1:0 (lane 1), 1:0.5 (lane 2), 1:1 (lane 3), 1:2 (lane 4), 1:4 (lane 5), 1:8 (lane 6), and 1:10 (lane 7). pckp (1.5 μM) in the absence of FBP 
(a) and the gray value determined using Quantity one (b). pckp (1.5 μM) in the presence of 1 mM FBP (c) and the gray value (d). ITC experiment with 
15 mM wild‑type Cra or mutant variants binding to 1 mM pckp DNA with 50 mM FBP (e)
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the relationship, and a positive correlation between the 
binding affinity of Cra for FBP and succinate produc-
tion was demonstrated for the first time. The highest 
succinate production of 92.7  g/L was obtained using 
the optimal mutant strain (Tang1683) with the highest 
binding affinity. The inhibitory effect caused by FBP was 
eliminated, likely because of the enhanced binding affin-
ity between Cra and FBP or by mutations at active sites. 
Most genes and enzymes involved in PEP carboxylation, 
the glyoxylate pathway, and the reductive TCA cycle 
were activated upon mutation of Cra, either directly or 
indirectly, especially pck and aceB, ultimately contribut-
ing to succinate biosynthesis.
Abbreviations
Cra: catabolite repressor/activator; TFs: transcription factors; F1P: fructose‑
1‑phosphate; FBP: fructose‑1,6‑bisphosphate; RT‑qPCR: reverse transcription 
quantitative polymerase chain reaction; PFK: phosphofructokinase; PPC: 
Additional files
Additional file 1: Table S1. Strains and plasmids used in this study.
Additional file 2: Table S2. Primers used in this study.
Additional file 3: Table S3. The relationship between succinate produc‑
tion and the affinity of Cra for FBP.
Additional file 4: Figure S1. Time courses of fed‑batch cultures of the 
17 three‑point mutant strains in 7.5‑L bioreactor.
Fig. 8 The combination of Cra and acep by EMSA and ITC experiments. EMSA experiment with increasing concentrations of pure Cra protein. Molar 
ratios of acep:Cra were 1:0 (lane 1), 1:0.5 (lane 2), 1:1 (lane 3), 1:2 (lane 4), 1:4 (lane 5), 1:8 (lane 6), and 1:10 (lane 7). acep (1.5 μM) in the absence of FBP 
(a) and the gray value determined using Quantity one (b). acep (1.5 μM) in the presence of 1 mM FBP (c) and the gray value (d). ITC experiment with 
15 mM wild‑type Cra or mutations binding to 1 mM acep DNA with 50 mM FBP (e)
Page 14 of 15Wei et al. Biotechnol Biofuels  (2016) 9:264 
phosphoenolpyruvate carboxylase; PCK: phosphoenolpyruvate carboxykinase; 
MDH: malate dehydrogenase; FUM: fumarase; FRD: fumarate reductase; MS: 
malate synthetase; ICL: isocitrate lyase; CS: citrate synthetase; ICDH: isocitrate 
dehydrogenase; ITC: isothermal titration microcalorimetry; EMSA: electropho‑
retic mobility shift assay; TCA: tricarboxylic acid; IclR: isocitrate lyase regulator; 
CRP: cyclic AMP receptor protein.
Authors’ contributions
LNW and LWZ contributed equally to this manuscript. LWZ and YJT conceived 
the project. LNW and LWZ carried out the experiments. LWZ analyzed the data 
and drafted the manuscript. YJT revised the manuscript. All authors read and 
approved the final manuscript.
Acknowledgements
We would like to acknowledge Dr. David P. Clark (Southern Illinois University) 
for providing the E. coli strain.
Competing interests
The authors declare that they have no competing interests.
Availability of supporting data
Data supporting the conclusions of this article are included within the article 
and its additional files.
Consent for publication
All authors have approved the manuscript for publication.
Funding
The financial supports from the National Science Fund for Distinguished 
Young Scholars (NSFC, Project No. 21625602), the National Natural Science 
Foundation of China (NSFC, Project Nos. 21376066, 81503112, 21506049, 
and 31570054), and Hubei Provincial Natural Science Foundation for 
Innovative Research Team (2015CFA013) are gratefully acknowledged. Prof. 
Ya‑Jie Tang also thanks the National High Level Talents Special Support Plan 
(“Million People Plan”) by the Organization Department of the CPC Central 
Committee (2014), Training Program for Top Talents in Hubei Province 
(2013), and Training Program for Huanghe Talents in Wuhan Municipality 
(2014).
Received: 13 September 2016   Accepted: 1 December 2016
References
 1. Li Y, Huang B, Wu H, Li Z, Ye Q, Zhang YHP. Production of succinate from 
acetate by metabolically engineered Escherichia coli. ACS Synth Biol. 2016. 
doi:10.1021/acssynbio.6b00052.
 2. Li Y, Li M, Zhang X, Yang P, Liang Q, Qi Q. A novel whole‑phase succinate 
fermentation strategy with high volumetric productivity in engineered 
Escherichia coli. Bioresour Technol. 2013;149:333–40.
 3. Yu JH, Zhu LW, Xia ST, Li HM, Tang YL, Liang XH, Chen T, Tang YJ. 
Combinatorial optimization of CO2 transport and fixation to improve 
succinate production by promoter engineering. Biotechnol Bioeng. 
2016;113(7):1531–41.
 4. Wu H, Li ZM, Zhou L, Ye Q. Improved succinic acid production in anaero‑
bic culture of a pflB ldhA double mutant of Escherichia coli by enhancing 
the anaplerotic activities in preceding aerobic culture. Appl Environ 
Microbiol. 2007;73(24):7837–43.
 5. Chen CX, Ding SP, Wang DZ, Li ZM, Ye Q. Simultaneous saccharification 
and fermentation of cassava to succinic acid by Escherichia coli NZN111. 
Bioresour Technol. 2014;163:100–5.
 6. Chong H, Geng H, Zhang H, Song H, Huang L, Jiang R. Enhancing E. coli 
isobutanol tolerance through engineering its global transcription factor 
cAMP receptor protein (CRP). Biotechnol Bioeng. 2014;111(4):700–8.
 7. Zhang F, Ouellet M, Batth TS, Adams PD, Petzold CJ, Mukhopadhyay A, 
Keasling JD. Enhancing fatty acid production by the expression of the 
regulatory transcription factor FadR. Metab Eng. 2012;14:653–60.
 8. Zhou D, Yang R. Global analysis of gene transcription regulation in 
prokaryotes. Cell Mol Life Sci. 2006;63(19–20):2260–90.
 9. Browning DF, Busby SJW. The regulation of bacterial transcription initia‑
tion. Nat Rev Microbiol. 2004;2(1):57–65.
 10. Ishihama A. Functional modulation of Escherichia coli RNA polymerase. 
Annu Rev Microbiol. 2010;54:499–518.
 11. Shimada T, Fujita N, Maeda M, Ishihama A. Systematic search for the 
cra‑binding promoters using genomic selex system. Genes Cells. 
2005;10(9):907–18.
 12. Chin AM, Feldheim DA, Saier MH Jr. Altered transcriptional pat‑
terns affecting several metabolic pathways in strains of Salmonella 
typhimurium which overexpress the fructose regulon. J Bacteriol. 
1989;171(5):2424–34.
 13. Cozzone AJ, El‑Mansi M. Control of isocitrate dehydrogenase catalytic 
activity by protein phosphorylation in Escherichia coli. J Mol Microbiol 
Biotechnol. 2005;9(3–4):132–46.
 14. Sarkar D, Siddiquee KAZ, Araúzo‑Bravo MJ, Oba T, Shimizu K. Effect of 
cra gene knockout together with edd and iclR genes knockout on the 
metabolism in Escherichia coli. Arch Microbiol. 2008;190(5):559–71.
 15. Ramseier TM, Bledig S, Michotey V, Feghali R, Saier MH Jr. The global regu‑
latory protein FruR modulates the direction of carbon flow in Escherichia 
coli. Mol Microbiol. 1995;16(6):1157–69.
 16. Ramseier TM. Cra and the control of carbon flux via metabolic pathways. 
Res Microbiol. 1996;147(6–7):489–93.
 17. Scarabel M, Penin F, Bonod‑Bidaud C, Nègre D, Cozzone AJ, Cortay JC. 
Overproduction, purification and structural characterization of the 
functional N‑terminal DNA‑binding domain of the fru repressor from 
Escherichia coli K‑12. Gene. 1995;153(1):9–15.
 18. Meinhardt S, Manley MW Jr, Becker NA, Hessman JA, Maher LJ 3rd, 
Swint‑Kruse L. Novel insights from hybrid LacI/GalR proteins: family‑wide 
functional attributes and biologically significant variation in transcription 
repression. Nucleic Acids Res. 2012;40(21):11139–54.
 19. Bledig SA, Ramseier TM, Saier MH Jr. FruR mediates catabolite activation 
of pyruvate kinase (pykF) gene expression in Escherichia coli. J Bacteriol. 
1996;178(1):280–3.
 20. Domínguez‑Cuevas P, Marín P, Busby S, Ramos JL, Marqués S. Roles 
of effectors in XylS‑dependent transcription activation: intra‑
molecular domain derepression and DNA binding. J Bacteriol. 
2008;190(9):3118–28.
 21. Cameron ADS, Redfield RJ. Non‑canonical CRP sites control competence 
regulons in Escherichia coli and many other γ‑proteobacteria. Nucleic 
Acids Res. 2006;34(20):6001–14.
 22. Fillenberg SB, Grau FC, Seidel G, Muller YA. Structural insight into operator 
dre‑sites recognition and effector binding in the GntR/HutC transcription 
regulator NagR. Nucleic Acids Res. 2015;43(2):1283–96.
 23. Zhu LW, Xia ST, Wei LN, Li HM, Yuan ZP, Tang YJ. Enhancing succinic acid 
biosynthesis in Escherichia coli by engineering its global transcription 
factor, catabolite repressor/activator (Cra). Sci Rep. 2016;6:36526.
 24. Donnelly MI, Millard CS, Clark DP, Chen MJ, Rathke JW. A novel fermenta‑
tion pathway in an Escherichia coli mutant producing succinic acid, acetic 
acid and ethanol. Appl Biochem Biotechnol. 1998;70–72:187–98.
 25. Mohan M, James P, Valsalan R, Nazeem PA. Molecular docking studies of 
phytochemicals from Phyllanthus niruri against Hepatitis B DNA polymer‑
ase. Bioinformation. 2015;11(9):426–31.
 26. Zhu LW, Li XH, Zhang L, Li HM, Liu JH, Yuan ZP, Chen T, Tang YJ. Activation 
of glyoxylate pathway without the activation of its related gene in succi‑
nate‑producing engineered Escherichia coli. Metab Eng. 2013;20:9–19.
 27. Gancedo JM, Gancedo C. Fructose‑1,6‑diphosphatase, phosphofructoki‑
nase and glucose‑6‑phosphate dehydrogenase from fermenting and 
non fermenting yeasts. Arch Microbiol. 1971;76(2):132–8.
 28. Van der Werf MJ, Guettler MV, Jain MK, Zeikus JG. Environmental and 
physiological factors affecting the succinate product ratio during 
carbohydrate fermentation by Actinobacillus sp. 130Z. Arch Microbiol. 
1997;167(6):332–42.
Page 15 of 15Wei et al. Biotechnol Biofuels  (2016) 9:264 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 29. Park SJ, Cotter PA, Gunsalus RP. Regulation of malate dehydrogenase 
(mdh) gene expression in Escherichia coli in response to oxygen, carbon, 
and heme availability. J Bacteriol. 1995;177(22):6652–6.
 30. Hill RL, Bradshaw RA. Fumarase. Methods Enzymol. 1969;13:91–9.
 31. de Jong‑Gubbels P, Vanrolleghem P, Heijnen S, van Dijken JP. Regulation 
of carbon metabolism in chemostat cultures of Saccharomyces cerevisiae 
grown on mixtures of glucose and ethanol. Yeast. 1995;11(5):407–18.
 32. Weitzman PDJ. Citrate synthase from Escherichia coli. Methods Enzymol. 
1969;13:22–6.
 33. Reeves HC, Daumy GO, Lin CC, Houston M. NADP+‑specific isocitrate 
dehydrogenase of Escherichia coli: I. Purification and characterization. 
Biochim Biophys Acta. 1972;258(1):27–39.
 34. Chavarría M, Santiago C, Platero R, Krell T, Casasnovas JM, de Lorenzo V. 
Fructose‑1‑phosphate is the preferred effector of the metabolic regulator 
Cra of Pseudomonas putida. J Biol Chem. 2011;286(11):9351–9.
 35. Tan Z, Zhu X, Chen J, Li Q, Zhang X. Activating phosphoenolpyruvate 
carboxylase and phosphoenolpyruvate carboxykinase in combina‑
tion for improving succinate production. Appl Environ Microbiol. 
2013;79(16):4838–44.
 36. Shimada T, Yamamoto K, Ishihama A. Novel members of the Cra 
regulon involved in carbon metabolism in Escherichia coli. J Bacteriol. 
2011;193(3):649–59.
 37. Zhang Z, Aboulwafa M, Saier MH Jr. Regulation of crp gene expression 
by the catabolite repressor/activator, Cra, Escherichia coli. J Mol Microbiol 
Biotechnol. 2014;24(3):135–41.
 38. Zheng D, Constantinidou C, Hobman JL, Minchin SD. Identification of the 
CRP regulon using in vitro and in vivo transcriptional profiling. Nucleic 
Acids Res. 2004;32(19):5874–93.
